bluebird bio Stock Price. Everything You Need To Know About The bluebird bio Stock!
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. The company is headquartered in Somerville, Massachusetts and currently employs 323 full-time employees. The company went IPO on 2013-06-19. The firm is principally focused on researching, developing and commercializing gene therapies for genetic diseases. The Company’s gene therapy programs in genetic diseases include programs for B-thalassemia; LentiGlobin product candidate as a treatment for sickle cell disease (SCD), and elivaldogene autotemcel (eli-cel) as a treatment for cerebral adrenoleukodystrophy (CALD). The company is using a lentiviral vector (LVV) platform, it custom designs each of its therapies to address the underlying cause of disease. The firm is developing lovotibeglogene autotemcel (lovo-cel) as a one-time treatment for patients with SCD, a genetic disease caused by a single mutation in the B-globin gene that leads to the production of abnormal sickle hemoglobin (HbS). The BLA for betibeglogene autotemcel (beti-cel) is for B-thalassemia in patients who receive regular red blood cell (RBC) transfusions.
bluebird bio Stock Price. Everything You Need To Know About The bluebird bio Stock! performance
- Employees 323
- Company HQ Somerville
- Website https://www.bluebirdbio.com/
- BLUE Asset Type Common Stock
- BLUE Market Capitalization 177.9M
- Earnings Per Share -0.63
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you looking to invest in the stock of a promising biotech company? Look no further than bluebird bio. This renowned company is revolutionizing the field of gene therapy, focusing on developing treatments for severe genetic diseases and cancer. With its cutting-edge research and innovative therapies, bluebird bio presents a compelling investment opportunity. Now, you may be wondering how to invest in bluebird bio from Malaysia, Thailand, Indonesia, or Vietnam. The good news is that Zorion, an investment platform, makes it possible for retail investors from these countries to easily invest in US stocks like bluebird bio. With Zorion’s user-friendly interface and comprehensive investment insights, you can make informed decisions and stay updated on bluebird bio’s performance. Moreover, Zorion offers a range of resources and educational materials to further enhance your investment knowledge. Whether you’re a novice investor or an experienced one, Zorion provides the tools and support you need to navigate the world of investing in bluebird bio and other stocks successfully. Don’t miss out on the opportunity to invest in a company that’s pioneering life-changing therapies. Take advantage of Zorion’s investment platform to invest in bluebird bio and watch your portfolio thrive. Start your investment journey today!
